- Oct 22, 2009
- 71
- 0
- 0
Moser admitted Conconi blood-doped him for his 1984 hour record, and if you look at Moser's achievements that same year - the year he turned 33, FFS - it's pretty clear that Dr 57% was already getting some pretty remarkable benefits out of transfusions.
Moser ended 1983 with a single and rather underwhelming victory to his name: Milano-Torino. In 1984, along with the world hour record, he bagged Milan-San Remo, the Giro del Lazio and the national individual pursuit championship. Oh yeah - and the Giro GC.
The '84 Giro was by all accounts a relatively flat route, but Moser's victory still suggests to me that Conconi was administering transfusions that could significantly enhance performance over long durations - days or even weeks.
Conconi certainly knew their value for one-off endurance events by then:
In 1982, Alberto Cova burnt off the field to win the European Championships 10,000m title. He repeated it at the following year's World Championships and, in 1984, won gold in Los Angeles. Cova seemed a genuine phenomenon until his admission that his blood was doped. Conconi performed all Cova's transfusions.
Conconi claimed to have stopped administering transfusions to sportsmen and women in 1985, though Italian Olympic skiers have said he carried on with them until 1988. Why stop then? Given the extraordinary results he'd been getting via transfusions I can't believe he'd have just given up doing them unless he'd found a superior alternative. EPO, obviously, which was launched that year in Europe by both Amgen and Boehringer Mannheim.
On topic, I'd therefore imagine that the first EPO user in the peloton was a Conconi client, in 1988.
Moser ended 1983 with a single and rather underwhelming victory to his name: Milano-Torino. In 1984, along with the world hour record, he bagged Milan-San Remo, the Giro del Lazio and the national individual pursuit championship. Oh yeah - and the Giro GC.
The '84 Giro was by all accounts a relatively flat route, but Moser's victory still suggests to me that Conconi was administering transfusions that could significantly enhance performance over long durations - days or even weeks.
Conconi certainly knew their value for one-off endurance events by then:
In 1982, Alberto Cova burnt off the field to win the European Championships 10,000m title. He repeated it at the following year's World Championships and, in 1984, won gold in Los Angeles. Cova seemed a genuine phenomenon until his admission that his blood was doped. Conconi performed all Cova's transfusions.
Conconi claimed to have stopped administering transfusions to sportsmen and women in 1985, though Italian Olympic skiers have said he carried on with them until 1988. Why stop then? Given the extraordinary results he'd been getting via transfusions I can't believe he'd have just given up doing them unless he'd found a superior alternative. EPO, obviously, which was launched that year in Europe by both Amgen and Boehringer Mannheim.
On topic, I'd therefore imagine that the first EPO user in the peloton was a Conconi client, in 1988.